Skip to content

Axogen AXGN Price / sales

Price / sales at other companies

Baxter International logo
Baxter InternationalBAX
0.8×-0.9×
Stryker logo
StrykerSYK
-1.1×
LeMaitre Vascular logo
LeMaitre VascularLMAT
9.7×+1.3×
Medtronic logo
MedtronicMDT
2.9×-0.4×

Other financials

Income statement

See full
Revenue$61.5M+26.6%
Gross profit$46.2M+32.2%
Operating income-$2.8M-70.5%
Net income-$19.6M-411%
EPS (diluted)-$0.38-375%

Balance sheet

See full
Cash & equivalents$84.7M+251%
Total debt$20.6M-69.8%
Total equity$244.8M+132%
Total assets$289.5M+47.6%

Cash flow

See full
Operating cash flow$1.6M+112%
CapEx$2.8M+989%
Free cash flow-$1.2M+90.9%

Valuation

See full
Market cap$2.38B+110%
Enterprise value$2.31B+91.4%

Profitability

See full
Gross margin75%+0.8pp
Operating margin-3.8%
Net margin-13.2%-22.8pp
FCF margin-12.9%-3.8pp

Returns & leverage

See full
Return on equity-18%-70.5pp
Debt / equity0.1×-0.6×
Current ratio7.1×+2.8×

Where this comes from

Calculated from Axogen’s reported figures.

Based on the most recent quarter.

The official record: Axogen’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Axogen's price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Axogen's price / sales?
Axogen (AXGN) reported price / sales of 7.2× in Q1 2026.
How has Axogen's price / sales changed year-over-year?
Axogen's price / sales increased by 71.2% year-over-year, from 4.2× to 7.2×.
What is the long-term trend for Axogen's price / sales?
Over 5 years (2020 to 2025), Axogen's price / sales has grown at a 0.7% compound annual growth rate (CAGR), from 6.5× to 6.7×.
What does price / sales mean?
Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.